CD40 mediated activation of gingival and periodontal ligament fibroblasts.

CD40 is a 50 kDa transmembrane protein important for regulating B lymphocyte proliferation and differentiation. This novel activation antigen is primarily expressed by hematopoietic cells including B lymphocytes, follicular dendritic cells, and monocytes. Recently, human fibroblasts from a variety of tissues were shown to display CD40; however, its function was unknown. Cellular responses mediated by CD40 are naturally triggered by its counter-receptor, the CD40 ligand, which is displayed on activated T cells, mast cells, eosinophils, basophils, and B lineage cells. This study investigated the functional significance of CD40 expression on periodontal fibroblasts, in the context of periodontal inflammation. The experiments reported herein demonstrate constitutive CD40 expression on cultured periodontal ligament (PDL) and gingival fibroblasts. Interestingly, cells of gingival origin displayed up to 13-fold higher constitutive levels of CD40, versus fibroblasts from PDL. Interferon gamma (IFN gamma) treatment enhanced CD40 expression on PDL and gingival fibroblasts, with up to 61-fold induction of expression. Immunohistochemical staining was used to detect CD40 on fibroblastic cells in both normal and acutely inflamed gingival tissue. Expression of CD40 in inflamed tissue was significantly higher than in uninflamed tissue. Western blot analysis of anti-CD40 triggered cells revealed the induction of tyrosine phosphorylation on a 50 kDa protein in PDL and gingival fibroblasts. These results indicate that CD40 is an active signaling conduit in periodontal fibroblasts. This concept was further substantiated by the fact that CD40 engagement stimulated interleukin 6 (IL-6) production by gingival fibroblasts, but not periodontal ligament fibroblasts. Overall, these results demonstrate that CD40 on periodontal fibroblasts may functionally interact with CD40L-expressing cells. This CD40/CD40L interaction can stimulate fibroblast activation and synthesis of the proinflammatory cytokine IL-6.

[1]  R. Looney,et al.  CD40 expression by human fibroblasts. , 1995, Clinical immunology and immunopathology.

[2]  S. Pollock,et al.  Gingival interleukin-6 concentration following phase I therapy. , 1995, Journal of periodontology.

[3]  P. Kiener,et al.  Expression of functional CD40 by vascular endothelial cells , 1995, The Journal of experimental medicine.

[4]  L. Davis,et al.  The CD40 ligand expressed by human B cells costimulates B cell responses. , 1995, Journal of immunology.

[5]  R. Phipps,et al.  Interleukin-6 is an autocrine growth factor for murine lung fibroblast subsets. , 1994, American journal of respiratory cell and molecular biology.

[6]  T. Foy,et al.  The expansive role of CD40 and its ligand, gp39, in immunity. , 1994, Seminars in immunology.

[7]  J. Parsons,et al.  CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein , 1994, The Journal of experimental medicine.

[8]  P. Lipsky,et al.  Immunoregulatory role of CD40 in human B cell differentiation. , 1993, Journal of immunology.

[9]  C. Maliszewski,et al.  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion , 1992, The Journal of experimental medicine.

[10]  I. Stamenkovic,et al.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.

[11]  H. Spits,et al.  CD40 is functionally expressed on human thymic epithelial cells. , 1992, Journal of immunology.

[12]  I. Stamenkovic,et al.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Clark,et al.  Soluble forms of CD40 inhibit biologic responses of human B cells. , 1992, Journal of immunology.

[14]  E. Clark,et al.  Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.

[15]  R. Genco Host Responses in Periodontal Diseases: Current Concepts. , 1992, Journal of periodontology.

[16]  I. Maclennan,et al.  Maturation and Dispersal of B‐Cell Clones during T Cell‐Dependent Antibody Responses , 1992, Immunological reviews.

[17]  C. McCulloch,et al.  Role of fibroblast subpopulations in periodontal physiology and pathology. , 1991, Journal of periodontal research.

[18]  I. Maclennan,et al.  Recombinant 25‐kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis , 1991, European journal of immunology.

[19]  E. Clark,et al.  CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. , 1991, Journal of immunology.

[20]  A. Saxon,et al.  CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. , 1991, Journal of immunology.

[21]  J. Banchereau,et al.  Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen , 1991, The Journal of experimental medicine.

[22]  J. Banchereau,et al.  Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. , 1991, Science.

[23]  J. Ledbetter,et al.  Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. , 1990, Blood.

[24]  R. Geha,et al.  CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells , 1990, The Journal of experimental medicine.

[25]  T. Lebien,et al.  Analysis of expression and function of CD40 on normal and leukemic human B cell precursors. , 1990, Leukemia.

[26]  E. Clark,et al.  Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. , 1990, Journal of immunology.

[27]  I. Maclennan,et al.  Mechanism of antigen-driven selection in germinal centres , 1989, Nature.

[28]  J. Banchereau,et al.  Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals. , 1989, Journal of immunology.

[29]  J. Banchereau,et al.  Activation of human B lymphocytes through CD40 and interleukin 4 , 1989, European journal of immunology.

[30]  G. Freeman,et al.  Isolated human follicular dendritic cells display a unique antigenic phenotype , 1989, The Journal of experimental medicine.

[31]  L. Young,et al.  Identification of a human epithelial cell surface protein sharing an epitope with the C3d/epstein‐barr virus receptor molecule of B lymphocytes , 1989, International journal of cancer.

[32]  I. Stamenkovic,et al.  A B‐lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. , 1989, The EMBO journal.

[33]  S. Tatter,et al.  Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection. , 1989, Journal of immunology.

[34]  R. Zinkernagel,et al.  Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients , 1988, The Journal of experimental medicine.

[35]  E. Clark,et al.  Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). , 1987, Journal of immunology.

[36]  E. Clark,et al.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Page,et al.  Heterogeneity of normal human diploid fibroblasts: isolation and characterization of one phenotype. , 1984, Science.

[38]  R. Page,et al.  C1Q receptors on cultured human gingival fibroblasts: analysis of binding properties. , 1983, Journal of immunology.

[39]  J. Banchereau,et al.  The CD40 antigen and its ligand. , 1994, Annual review of immunology.